{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2020:YRPCL6GPKV6WEVJKSIGIELD3FL","short_pith_number":"pith:YRPCL6GP","schema_version":"1.0","canonical_sha256":"c45e25f8cf557d62552a920c822c7b2ad4e5d5f71c7c4ee71d5ce417f9a38870","source":{"kind":"arxiv","id":"2008.06034","version":1},"attestation_state":"computed","paper":{"title":"Tetracycline as an inhibitor to the coronavirus SARS-CoV-2","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["q-bio.QM"],"primary_cat":"q-bio.BM","authors_text":"Neelesh A. Patankar, Tom Y. Zhao","submitted_at":"2020-08-13T17:46:46Z","abstract_excerpt":"The coronavirus SARS-CoV-2 remains an extant threat against public health on a global scale. Cell infection begins when the spike protein of SARS-CoV-2 binds with the cell receptor, angiotensin-converting enzyme 2 (ACE2). Here, we address the role of Tetracycline as an inhibitor for the receptor-binding domain (RBD) of the spike protein. Targeted molecular investigation show that Tetracycline binds more favorably to the RBD (-9.40 kcal/mol) compared to Chloroquine (-6.31 kcal/mol) or Doxycycline (-8.08 kcal/mol) and inhibits attachment to ACE2 to a greater degree (binding efficiency of 2.98 $\\"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2008.06034","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.BM","submitted_at":"2020-08-13T17:46:46Z","cross_cats_sorted":["q-bio.QM"],"title_canon_sha256":"e64f8a01c1a7babf759d58908092db5b0614e32546bb30a7997d2828497c9e2c","abstract_canon_sha256":"6fa4ee294051d2b38bc8af814f50672ef05b839c7b22a51aeb1f3204d491be1c"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T02:17:30.742004Z","signature_b64":"4X++p6t2mavuJP0QGMxe57zAtyELBTEvRWgopmaxLhbBCQitPT+MrSw4XCU/3tupkPmU320bVRE/XBw9HR89Bw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"c45e25f8cf557d62552a920c822c7b2ad4e5d5f71c7c4ee71d5ce417f9a38870","last_reissued_at":"2026-07-05T02:17:30.741546Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T02:17:30.741546Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Tetracycline as an inhibitor to the coronavirus SARS-CoV-2","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["q-bio.QM"],"primary_cat":"q-bio.BM","authors_text":"Neelesh A. Patankar, Tom Y. Zhao","submitted_at":"2020-08-13T17:46:46Z","abstract_excerpt":"The coronavirus SARS-CoV-2 remains an extant threat against public health on a global scale. Cell infection begins when the spike protein of SARS-CoV-2 binds with the cell receptor, angiotensin-converting enzyme 2 (ACE2). Here, we address the role of Tetracycline as an inhibitor for the receptor-binding domain (RBD) of the spike protein. Targeted molecular investigation show that Tetracycline binds more favorably to the RBD (-9.40 kcal/mol) compared to Chloroquine (-6.31 kcal/mol) or Doxycycline (-8.08 kcal/mol) and inhibits attachment to ACE2 to a greater degree (binding efficiency of 2.98 $\\"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2008.06034","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2008.06034/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2008.06034","created_at":"2026-07-05T02:17:30.741604+00:00"},{"alias_kind":"arxiv_version","alias_value":"2008.06034v1","created_at":"2026-07-05T02:17:30.741604+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2008.06034","created_at":"2026-07-05T02:17:30.741604+00:00"},{"alias_kind":"pith_short_12","alias_value":"YRPCL6GPKV6W","created_at":"2026-07-05T02:17:30.741604+00:00"},{"alias_kind":"pith_short_16","alias_value":"YRPCL6GPKV6WEVJK","created_at":"2026-07-05T02:17:30.741604+00:00"},{"alias_kind":"pith_short_8","alias_value":"YRPCL6GP","created_at":"2026-07-05T02:17:30.741604+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL","json":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL.json","graph_json":"https://pith.science/api/pith-number/YRPCL6GPKV6WEVJKSIGIELD3FL/graph.json","events_json":"https://pith.science/api/pith-number/YRPCL6GPKV6WEVJKSIGIELD3FL/events.json","paper":"https://pith.science/paper/YRPCL6GP"},"agent_actions":{"view_html":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL","download_json":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL.json","view_paper":"https://pith.science/paper/YRPCL6GP","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2008.06034&json=true","fetch_graph":"https://pith.science/api/pith-number/YRPCL6GPKV6WEVJKSIGIELD3FL/graph.json","fetch_events":"https://pith.science/api/pith-number/YRPCL6GPKV6WEVJKSIGIELD3FL/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL/action/timestamp_anchor","attest_storage":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL/action/storage_attestation","attest_author":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL/action/author_attestation","sign_citation":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL/action/citation_signature","submit_replication":"https://pith.science/pith/YRPCL6GPKV6WEVJKSIGIELD3FL/action/replication_record"}},"created_at":"2026-07-05T02:17:30.741604+00:00","updated_at":"2026-07-05T02:17:30.741604+00:00"}